Prognostic Factors of Patients With COVID-19

Chongqing Medical University201 enrolled

Overview

The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China has been declared a public health emergency of international concern. Despite lower mortality rate, SARS-CoV-2 has killed more people than SARS and MERS and the number keeps growing. Epidemic studies have been well described clinical features of patients with COVID-19, with the disease severity being an independent predictor of poor outcome. However, there is still no research investigating the prognostic factors of patients with COVID-19.

Study Type

OBSERVATIONAL

Enrollment

201

Conditions

SARS-CoV-2 Outcome, Fatal

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult aged \>=18years old; * Diagnosed with CONVID19. Diagnostic criteria including: Laboratory (RT-PCR) confirmed SARS-Cov-2 infection; CT of the lung conformed to the manifestation of viral pneumonia. * Criteria for severe or critical ill conditions: Respiratory rate \>=30/min; or Rest SPO2\<=93%; or PaO2/FiO2\<=300mmHg. Exclusion Criteria: * Near-death state (expected survival time less than 24 hours); * Malignant tumor; * Pregnancy or puerperium women; * Patients who refused to participant.

Locations (1)

The First Affiliated Hospital of Chongqing Medical University

Chongqing, China

Outcomes

Primary Outcomes

all-cause mortality

Time frame: 30 days

Secondary Outcomes

all-cause mortality

Time frame: 15 days

Severe state

Criteria for severe or critical ill conditions: Respiratory rate \>=30/min; or Rest SPO2\<=93%; or PaO2/FiO2\<=300mmHg.

Time frame: 15 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.